Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Mycopathologia ; 180(3-4): 237-43, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26045285

ABSTRACT

Majocchi's granuloma (MG) is a rare deep skin dermatophyte infection that can occur either in immunocompetent or in immunocompromised individuals. Oral itraconazole or terbinafine is considered to be the first choice of treatment. We report an immunocompetent man with deep nodular form of MG, the form which is generally found in immunosuppressed individuals. Previous treatment with either oral itraconazole or terbinafine yielded no apparent improvement. After a series of examination, the man was diagnosed as having Trichophyton rubrum-induced MG mixed with bacterial infection as evidenced by growth of Klebsiella pneumoniae in tissue bacterial culture. The patient was treated with a combination of cefoselis and levofloxacin for bacterial clearance followed by voriconazole treatment. After approximately 4 months of voriconazole treatment, the lesions completely resolved. Alternative medicine (voriconazole) can be considered in case of refractory infections during MG treatment.


Subject(s)
Antifungal Agents/administration & dosage , Coinfection/drug therapy , Granuloma/drug therapy , Tinea/drug therapy , Trichophyton/isolation & purification , Voriconazole/administration & dosage , Anti-Bacterial Agents/administration & dosage , Ceftizoxime/administration & dosage , Ceftizoxime/analogs & derivatives , Coinfection/complications , Coinfection/pathology , Granuloma/microbiology , Granuloma/pathology , Humans , Klebsiella Infections/complications , Klebsiella Infections/drug therapy , Klebsiella Infections/pathology , Klebsiella pneumoniae/isolation & purification , Levofloxacin/administration & dosage , Male , Middle Aged , Tinea/complications , Tinea/pathology , Treatment Outcome
3.
Med Mycol ; 49(3): 296-302, 2011 Apr.
Article in English | MEDLINE | ID: mdl-20854230

ABSTRACT

We present the third case of phaeohyphomycosis caused by Veronaea botryosa in China and the tenth case worldwide. A 16-year-old Chinese girl developed crusted, verrucous lesions, initially on the left ear and later on the left buttock, within 2-5 months of receiving an ear piercing. Histopathological examination of biopsy specimens confirmed diagnosis of subcutaneous phaeohyphomycosis. Microscopic examination of the colonies recovered in culture from a portion of the biopsy specimen resulted in the identification of Veronaea botryosa based primarily on the presence of two-celled, brownish pigmented, cylindrical conidia produced sympodially from erect conidiogenous cells. The lesions significantly improved with daily oral treatment with itraconazole 400 mg and adjuvant thermotherapy for 6 months. A maintenance therapy with low dose itraconazole was prescribed in order to achieve clinical and mycological cure. A two-year follow-up didn't reveal any recurrence of infection. Our case is the first report of V. botryosa infection associated with a cosmetic procedure, which suggests that skin piercing could precipitate V. botryosa or other dematiaceous, as well as opportunistic fungal infections.


Subject(s)
Ascomycota/isolation & purification , Body Piercing/adverse effects , Mycoses/diagnosis , Mycoses/pathology , Adolescent , Antifungal Agents/administration & dosage , Biopsy , China , Female , Histocytochemistry , Humans , Hyperthermia, Induced , Itraconazole/administration & dosage , Microscopy , Mycoses/therapy , Subcutaneous Tissue/pathology , Treatment Outcome
4.
Scand J Immunol ; 68(6): 589-97, 2008 Dec.
Article in English | MEDLINE | ID: mdl-19055697

ABSTRACT

Interleukin (IL)-17 is a proinflammatory cytokine primarily secreted by Th17 cells, which are a CD4(+) T-cell subset. Th17 cells and IL-17 are important in the pathogenesis of multiple sclerosis and in its established animal model, experimental autoimmune encephalomyelitis (EAE). However, it is unclear whether IL-17 contributes to EAE immune tolerance. We used the myelin basic protein (MBP) peptide MBP 68-86 to induce nasal tolerance to EAE, and simultaneously interfered with the tolerance by treatment with different doses of IL-17. We found that IL-17 dramatically interfered with MBP 68-86-induced immune tolerance. IL-17 administration increased IL-6 release, skewing T cell differentiation towards Th17 cells and decreasing the number of Treg cells. This led to an imbalance between Treg cells and Th17 cells and spurred the development of EAE.


Subject(s)
Encephalomyelitis, Autoimmune, Experimental/drug therapy , Immune Tolerance , Interleukin-17/pharmacology , Interleukin-6/metabolism , Myelin Basic Protein/therapeutic use , Peptide Fragments/therapeutic use , Animals , CD4-Positive T-Lymphocytes/immunology , Cell Differentiation , Cell Proliferation , Encephalomyelitis, Autoimmune, Experimental/immunology , Female , Interleukin-17/immunology , Interleukin-6/immunology , Lymphocyte Activation , Multiple Sclerosis/drug therapy , Multiple Sclerosis/immunology , Rats , Rats, Inbred Lew , T-Lymphocyte Subsets/immunology , T-Lymphocytes, Regulatory/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...